openPR Logo
Press release

National Ataxia Foundation Earns Four-Star Rating from Charity Navigator for Fourth Consecutive Year

07-22-2016 09:40 AM CET | Health & Medicine

Press release from: S&A Communications

/ PR Agency: S&A Communications
Minneapolis, July 19, 2016 ¬– The National Ataxia Foundation, based in Minneapolis, received a four-star rating from Charity Navigator, America’s premier charity evaluator, for the fourth consecutive year. ¬Charity Navigator annually reviews thousands of charities, rating only one in four organizations with four stars.

Established in 1957, NAF is a membership-supported nonprofit organization dedicated to improving the lives of persons affected by Ataxia through support, education and research. Its primary goal is to support promising Ataxia research and to provide essential programs and services for Ataxia families.

Ataxia is a group of devastating, often fatal, rare neurological disorders. It’s progressive, too often strikes children, and can affect anyone. People with Ataxia have issues with coordination, balance, fine motor skills, speech, swallowing, and eye movements. Ataxia can be hereditary or non-hereditary.

Charity Navigator is the nation’s largest and most-utilized evaluator of charities. Its team of professional analysts strives to help donors by examining thousands of nonprofit financial documents to develop an unbiased, objective, number-based rating system of America’s charities. Charity Navigator focuses on a charity’s performance in terms of financial health, accountability and transparency, with the goal of helping donors make intelligent giving decisions.

“We are proud to yet again be honored with a four-star rating from Charity Navigator,” said Michael Parent, executive director of the National Ataxia Foundation. “It is always a pleasure to be recognized for the work we put in to help all of those affected by Ataxia.”

For more informational about the National Ataxia Foundation, visit www.ataxia.org.

Since 1957, The National Ataxia Foundation is dedicated to improving the lives of persons affected by Ataxia through support, education and research. NAF research programs fund research studies throughout the world. The Foundation supports research in dominant, recessive and sporadic Ataxia. Learn more about the National Ataxia Foundation at http://www.ataxia.org.

Media Contact:
Glenn Gillen
ggillen@sacommunications.com
301 Cascade Pointe Lane
Cary, NC 27513

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release National Ataxia Foundation Earns Four-Star Rating from Charity Navigator for Fourth Consecutive Year here

News-ID: 350723 • Views:

More Releases for Ataxia

Friedreich's Ataxia Market Detailed Industry Report Analysis 2025-2034
Introduction Friedreich's ataxia (FA) is a rare and hereditary neurodegenerative disorder characterized by progressive loss of coordination and neurological function, often accompanied by cardiomyopathy and other complications. For decades, treatments have focused only on symptom management. Recently, gene therapies, novel pharmacological candidates, and targeted diagnostics are transforming the landscape, supported by increased patient advocacy and rare disease funding. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71063 Market Overview • Market Size (2024): USD
Key Trends Reshaping the Progressive Ataxia And Weakness Disorders Market: Innov …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Progressive Ataxia And Weakness Disorders Market Size Growth Forecast: What to Expect by 2025? The market size for progressive ataxia and weakness disorders has seen a swift expansion in the past few years. It is projected to escalate from $34.72 billion in 2024 to $38.67 billion in 2025, boasting
Ataxia Pipeline: Advancing Therapeutics and 32+ Leading Companies Shaping the At …
The therapeutic landscape for Ataxia, a group of rare neurological disorders characterized by impaired coordination and balance, is witnessing significant momentum, driven by advances in genetic research, biomarker development, and a surge in innovative therapies. Biopharmaceutical companies such as Retrotope, Reata Pharmaceuticals, PTC Therapeutics, Metro International Biotech, LLC, and Design Therapeutics are leading the charge, targeting key pathways like mitochondrial dysfunction, cerebellar degeneration, and RNA-based mechanisms to develop disease-modifying treatments
Prominent Ataxia Market Trend for 2025: Revolutionizing Ataxia Treatment With Gr …
What industry-specific factors are fueling the growth of the ataxia market? The increasing rate of alcohol intake is projected to stimulate the expansion of the ataxia market in the future. Alcohol consumption typically involves the oral ingestion of an ethanol-containing drink. Chronic misuse of alcohol primarily causes cerebellar degeneration, a common type of acquired toxic ataxia. Those suffering from alcoholism often manifest lower limb postural tremors and gait ataxia. For example,
Spinocerebellar Ataxia Market Analysis: Opportunities & Forecast 2024-2031
Spinocerebellar Ataxia Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an
Fighting Ataxia: Market Report 2024 Spotlights Treatment Advancements
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Ataxia Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $51.3 billion In 2028 At A